Recombinant CCR2 (Plozalizumab Biosimilar) antibody

Catalog No. ABIN7675711

This Human Monoclonal antibody specifically detects CCR2 (Plozalizumab Biosimilar) in FACS, ELISA, BLI, Func and SPR. It exhibits reactivity toward Human.

Quick Overview for Recombinant CCR2 (Plozalizumab Biosimilar) antibody (ABIN7675711)

Target: CCR2 (Plozalizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CCR2 (Plozalizumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), ELISA, Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-CCR2 (Plozalizumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-CCR2 / CD192 Reference Antibody (plozalizumab)

Characteristics: Anti-CCR2 / CD192 Reference Antibody (plozalizumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for CCR2 (Plozalizumab Biosimilar)

Target: CCR2 (Plozalizumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P41597